Michael J. de la Merced
Posts
Unilever in Takeover Fight for Glaxo and Pfizer Consumer Health Business
Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.
TPG Goes Public in the Year’s First Big Stock Market Debut
The firm, which was valued at $9 billion in its I.P.O., must convince investors that it can compete with its publicly traded rivals.
Take-Two to Buy Zynga, Uniting Two Top Game Makers
Adding Zynga’s stable of app developers is meant to help Take-Two roll out more smartphone versions of its popular video game titles.
What’s Next for the Deal Boom?
After a record year of transactions in 2021, deal makers are expecting a slowdown in 2022. Here are three factors that could intensify it.
Is It Time for Big In-Person Events Again? Organizers Are Divided
Some big events are delaying their return to in-person gatherings, but the organizers of CES, the Winter Olympics and the Australian Open have decided it’s...
Pressure Mounts to Drop Activision’s Chief From Coca-Cola’s Board
A union-led investment group plans to ask the beverage maker not to renominate Bobby Kotick as a director, a call that comes after the group...
Athenahealth’s $17 Billion Takeover Is the Latest Private Equity Megadeal
Hellman & Friedman and Bain Capital are taking over the health care software company.
Johnson & Johnson Will Break Itself Up Into Two Companies
The corporate giant said it would spin off its consumer products division, leaving the company to manufacture and market drugs and medical devices.
Adam Neumann Has Regrets About WeWork: ‘It Went to My Head’
He also tried to revise the record about what happened.
Adam Neumann Has Regrets About WeWork: ‘It Went to My Head’
He also tried to revise the record about what happened.